Amplifon SpA
MIL:AMP
Relative Value
The Relative Value of one AMP stock under the Base Case scenario is 46.86 EUR. Compared to the current market price of 31.87 EUR, Amplifon SpA is Undervalued by 32%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
AMP Competitors Multiples
Amplifon SpA Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
IT |
Amplifon SpA
MIL:AMP
|
7.1B EUR | 3.1 | 45.7 | 14.8 | 29.1 | ||
US |
Mckesson Corp
NYSE:MCK
|
69.6B USD | 0.2 | 23.2 | 16.1 | 18.7 | ||
US |
Cencora Inc
NYSE:COR
|
45.7B USD | 0.2 | 24.5 | 12.5 | 17.6 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.9B USD | 0.1 | 39 | 8.7 | 11.7 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 21.4 | 11.3 | 15.2 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 1.4 | 21.3 | 15.5 | 15.5 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
60.5B HKD | 0.1 | 6.3 | 1.5 | 1.8 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 0.2 | 13.5 | 8 | 8 | |
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.2 | -5.1 | 3.9 | 19.2 |